Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience - Concepedia

Concepedia

Publication | Closed Access

Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience

79

Citations

26

References

2021

Year

Florian Eichhorn, Laura V. Klotz, Mark Kriegsmann, Helge Bischoff, Marc A. Schneider, Thomas Muley, Katharina Kriegsmann, Uwe Haberkorn, Claus Peter Heußel, Rajkumar Savai,

First Clinical ExperienceMedicineImmunologyImmune Checkpoint InhibitorBronchial NeoplasmCancer TreatmentImmunotherapyOncologyRadiation OncologyLung Cancer

References

	Year	Citations

Page 1

Page 1